+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vascular Disease Devices Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 220 Pages
  • January 2022
  • Region: Global
  • Allied Market Research
  • ID: 5561137
Description Jump to:
The global vascular disease devices market was valued at $26,522.24 million in 2020, and is projected to reach $ 51,802.14 million by 2030, registering a CAGR of 6.50% from 2021 to 2030.

The vascular diseases refer to any pathological condition that affects natural blood circulatory system, such as peripheral artery disease (PAD). The vascular diseases include stroke, peripheral artery disease (PAD), abdominal aortic aneurysm (AAA), carotid artery disease (CAD), arteriovenous malformation (AVM), critical limb-threatening ischemia (CLTI), pulmonary embolism (blood clots), deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and varicose veins. The incidence of vascular diseases has increased significantly over the last few years. According to the World Health Organization (WHO), an estimated 17.9 million people died from cardiovascular diseases (CVDs) in 2019. Vascular diseases may be caused due to high blood pressure, cholesterol deposition, injury, genetics, and infections. Diabetes, hypertension, obesity, alcohol consumption, and tobacco smoking are the risk factors for vascular diseases.

Specially designed devices such as balloons, stents, catheters, and filters are used to perform various vascular surgeries. The artery stent is a small, metal mesh tube that expands inside a coronary artery. A stent is often placed during or immediately after angioplasty. It helps prevent the artery from closing up again. Similarly, at the blockage, the balloon is inflated and the spring-like stent expands and locks into place inside the artery. The stent stays in the artery permanently to hold it open and improve blood flow to the heart. In addition, cardiac catheter is a very small, flexible, hollow tube put into a blood vessel in the groin, arm, or neck. Then surgeon threads it through the blood vessel into the aorta and the heart. The cardiac catheterization is used to diagnose and evaluate common heart and blood vessel problems such as chest pain or an abnormal stress test due to coronary artery disease, heart valve conditions like a leaky or narrowed valve, a high blood pressure condition in the lungs, or blood clots.

Increase in prevalence of vascular diseases worldwide, drive the growth of the vascular disease devices market. For instance, according to a report by the American Heart Association, in 2019, 197.2 million people were living with ischemic heart disease (IHD). In addition, increase in diabetes and hypertension propels the growth of the vascular disease devices market. According to the World Health Organization (WHO) in 2021, an estimated 1.28 billion adults aged 30-79 years worldwide have hypertension. The older people are more susceptible to vascular disease. Thus, rise in the geriatric population further contributed in the growth of vascular disease devices market. However, product recalls and failures may limit the growth of the market.

The vascular disease devices market is segmented on the basis of product, end-user and region. By product, the market is divided into stents, balloons, catheters, plaque modification devices, hemodynamic flow alteration devices, and others. The stents are further classified into coronary stents, peripheral stents, and stents-related products. The coronary stents are divided into drug-eluting stents bare-metal coronary stents and bioabsorbable stents. The peripheral stents are further classified as iliac, femoral-popliteal, renal, and carotid. The stents-related products are classified as synthetic grafts and vena cava filters.

The balloons are further divided into bare/normal balloons, drug-coated balloons, and scoring balloons. The catheters are classified as angiography, IVUS/OCT, and guiding.

By end-user, the market is divided into hospitals & cardiac centers and ambulatory surgical centers. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Medtronic, Boston Scientific Corporation, Abbott Laboratories, Becton Dickinson and Company, Terumo Corporation, Cordis, B. Braun Melsungen Ag, Ivascular, Merit Medical, and Koninklijke Philips N.V.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of the global vascular disease devices market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global vascular disease devices market growth

KEY MARKET SEGMENTS


By Product

  • Stents
  • Coronary Stents
  • Drug-eluting Stents
  • Bare-metal Coronary
  • Stents Bioabsorbable Stents
  • Peripheral Stents
  • Iliac
  • Femoral-Popliteal
  • Renal
  • Carotid
  • Stent Related Implant
  • Synthetic Grafts
  • Vena Cava Filters
  • Balloons
  • Bare/Normal balloon
  • Drug coated balloons
  • Scoring balloons
  • Catheters
  • Angiography
  • IVUS/OCT
  • Guiding
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Other

By End User

  • Hospitals and Cardiac Centers
  • Ambulatory Surgical Center

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Medtronic
  • Boston scientific corporation
  • Abbott laboratories
  • Becton Dickinson and company
  • Terumo Corporation
  • Cordis
  • B. Braun Melsungen AG
  • Ivascular
  • Merit Medical
  • Koninklijke Philips N.V.

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in prevalence of cardiovascular diseases
3.5.1.2. Rise in number of diabetes and hypertension patients
3.5.1.3. The R&D in vascular disease
3.5.2. Restraint
3.5.2.1. Product recall and failure
3.5.3. Opportunity
3.5.3.1. Increase in aging population.
3.5.4. Impact analysis
3.6. Impact analysis of COVID-19 on the vascular disease devices market
CHAPTER 4: VASCULAR DISEASES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Stents
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis by country
4.2.4. Market size and forecast, by stents types
4.2.4.1. Coronary Stents
4.2.4.2. Peripheral Stents
4.2.4.3. Stent Related Implant
1.2Balloons
4.2.5. Key market trends, growth factors, and opportunities
4.2.6. Market size and forecast, by region
4.2.7. Market analysis by country
4.2.7.1. Bare/Normal balloons
4.2.7.2. Drug coated balloons
4.2.7.3. Scoring balloons
1.3Catheters
4.2.8. Key market trends, growth factors, and opportunities
4.2.9. Market size and forecast, by region
4.2.10. Market analysis by country
4.2.10.1. Angiography
4.2.10.2. IVUS/OCT
4.2.10.3. Guiding
1.4Plaque Modification Devices
4.2.11. Key market trends, growth factors, and opportunities
4.2.12. Market size and forecast, by region
4.2.13. Market analysis by country
1.5Hemodynamic Flow Alteration Devices
4.2.14. Key market trends, growth factors, and opportunities
4.2.15. Market size and forecast, by region
4.2.16. Market analysis by country
1.6Others
4.2.17. Key market trends, growth factors, and opportunities
4.2.18. Market size and forecast, by region
4.2.19. Market analysis by country
CHAPTER 5: VASCULAR DISEASE DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals & cardiac centers
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Ambulatory Surgical Center
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
CHAPTER 6: VASCULAR DISEASE DEVICES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. vascular disease devices market, by product
6.2.2.1.2. U.S. vascular disease devices market, by end user
6.2.2.2. Canada
6.2.2.2.1. Canada vascular disease devices market, by product
6.2.2.2.2. Canada vascular disease devices market, by end user
6.2.2.3. Mexico
6.2.2.3.1. Mexico vascular disease devices market, by product
6.2.2.3.2. Mexico vascular disease devices market, by end user
6.2.3. North America vascular disease devices market, by product
6.2.4. North America vascular disease devices market, by end user
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany vascular disease devices market, by product
6.3.2.1.2. Germany vascular disease devices market, by end user
6.3.2.2. France
6.3.2.2.1. France vascular disease devices market, by product
6.3.2.2.2. France vascular disease devices market, by end user
6.3.2.3. UK
6.3.2.3.1. UK vascular disease devices market, by product
6.3.2.3.2. UK vascular disease devices market, by end user
6.3.2.4. Italy
6.3.2.4.1. Italy vascular disease devices market, by product
6.3.2.4.2. Italy vascular disease devices market, by end user
6.3.2.5. Spain
6.3.2.5.1. Spain vascular disease devices market, by product
6.3.2.5.2. Spain vascular disease devices market, by end user
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe vascular disease devices market, by product
6.3.2.6.2. Rest of Europe vascular disease devices market, by end user
6.3.3. Europe vascular disease devices market, by product
6.3.4. Europe vascular disease devices market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. China
6.4.2.1.1. China vascular disease devices market, by product
6.4.2.1.2. China vascular disease devices market, by end user
6.4.2.2. Japan
6.4.2.2.1. Japan vascular disease devices market, by product
6.4.2.2.2. Japan vascular disease devices market, by end user
6.4.2.3. India
6.4.2.3.1. India vascular disease devices market, by product
6.4.2.3.2. India vascular disease devices market, by end user
6.4.2.4. Australia
6.4.2.4.1. Australia vascular disease devices market, by product
6.4.2.4.2. Australia vascular disease devices market, by end user
6.4.2.5. South Korea
6.4.2.5.1. South Korea vascular disease devices market, by product
6.4.2.5.2. South Korea vascular disease devices market, by end user
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific vascular disease devices market, by product
6.4.2.6.2. Rest of Asia-Pacific vascular disease devices market, by end user
6.4.3. Asia-Pacific vascular disease devices market, by product
6.4.4. Asia-Pacific vascular disease devices market, by end user
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil vascular disease devices market, by product
6.5.2.1.2. Brazil vascular disease devices market, by end user
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia vascular disease devices market, by product
6.5.2.2.2. Saudi Arabia vascular disease devices market, by end user
6.5.2.3. South Africa
6.5.2.3.1. South Africa vascular disease devices market, by product
6.5.2.3.2. South Africa vascular disease devices market, by end user
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA vascular disease devices market, by product
6.5.2.4.2. Rest of LAMEA vascular disease devices market, by end user
6.5.3. LAMEA vascular disease devices market, by product
6.5.4. LAMEA vascular disease devices market, by end user
CHAPTER 7: COMPANY PROFILES
7.1. Koninklijke Philips N.V. (Philips)
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. Medtronic Plc.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segment
7.2.4. Product portfolio
7.2.5. Business performance
7.3. Abbott Laboratories.
7.3.1. Company overview
7.3.2. Operating business segment
7.3.3. Product portfolio
7.3.4. Business performance
7.3.5. Key strategic moves and developments
7.4. Boston scientific corporation.
7.4.1. Company overview
7.4.2. Operating business segment
7.4.3. Product portfolio
7.4.4. Business performance
7.4.5. Key strategic moves and developments
7.5. Becton Dickinson And Company.
7.5.1. Company overview
7.5.2. Operating business segment
7.5.3. Product portfolio
7.5.4. Business performance
7.6. Terumo Corporation.
7.6.1. Company overview
7.6.2. Operating business segment
7.6.3. Product portfolio
7.6.4. Business performance
7.6.5. Key strategic moves and developments
7.7. Cordis
7.7.1. Company overview
7.7.2. Operating business segment
7.7.3. Product portfolio
7.7.4. Business performance
7.8. B. BRAUN MELSUNGEN AG
7.8.1. Company overview
7.8.2. Operating business segment
7.8.3. Product portfolio
7.8.4. Business performance
7.9. IVASCULAR
7.9.1. Company overview
7.9.2. Operating business segment
7.9.3. Product portfolio
7.9.4. Key strategic moves and developments
7.10. Merit Medical Systems, Inc.
7.10.1. Company overview
7.10.2. Operating business segment
7.10.3. Product portfolio
7.10.4. Business performance
7.10.5. Key strategic moves and developments
List of Tables
TABLE 01. VASCULAR DISEASES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 02. VASCULAR DISEASE DEVICES MARKET FOR STENTS, BY REGION, 2020–2030 ($MILLION)
TABLE 01. VASCULAR DISEASE DEVICES MARKET FOR STENTS, BY TYPE, 2020-2030 ($MILLION)
TABLE 02. VASCULAR DISEASE DEVICES MARKET FOR BALLOONS, BY REGION, 2020–2030 ($MILLION)
TABLE 03. VASCULAR DISEASE DEVICES MARKET FOR CATHETERS, BY REGION, 2020–2030 ($MILLION)
TABLE 04. VASCULAR DISEASE DEVICES MARKET FOR PLAQUE MODIFICATION DEVICES, BY REGION, 2020–2030 ($MILLION)
TABLE 05. VASCULAR DISEASE DEVICES MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION, 2020–2030 ($MILLION)
TABLE 06. VASCULAR DISEASE DEVICES MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 07. VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 08. VASCULAR DISEASE DEVICES MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 09. VASCULAR DISEASE DEVICE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 10. VASCULAR DISEASE DEVICES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 11. NORTH AMERICA VASCULAR DISEASE DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 12. U.S. VASCULAR DISEASE DEVICES MARKET , BY PRODUCT, 2020-2030 ($MILLION)
TABLE 13. U.S. VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 14. CANADA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 15. CANADA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 16. MEXICO VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 17. MEXICO VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 18. NORTH AMERICA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 19. NORTH AMERICA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 20. EUROPE VASCULAR DISEASE DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 21. GERMANY VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 22. GERMANY VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 23. FRANCE VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 24. FRANCE VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 25. UK VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 26. UK VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 27. ITALY VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 28. ITALY VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 29. SPAIN VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 30. SPAIN VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31. REST OF EUROPE VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 32. REST OF EUROPE VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 33. EUROPE VASCULAR DISEASE DEVICES MARKET , BY PRODUCT, 2020-2030 ($MILLION)
TABLE 34. EUROPE VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35. ASIA-PACIFIC VASCULAR DISEASES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 36. CHINA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 37. CHINA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38. JAPAN VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 39. JAPAN VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 40. INDIA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 41. INDIA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 42. AUSTRALIA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 43. AUSTRALIA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44. SOUTH KOREA VASCULAR DISEASES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 45. SOUTH KOREA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 46. REST OF ASIA-PACIFIC VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 47. REST OF ASIA PACIFIC VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 48. ASIA-PACIFIC VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 49. ASIA-PACIFIC VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 50. LAMEA VASCULAR DISEASES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 51. BRAZIL VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 52. BRAZIL VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 53. SAUDI ARABIA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 54. SAUDI ARABIA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 55. SOUTH AFRICA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 56. SOUTH AFRICA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57. REST OF LAMEA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 58. REST OF LAMEA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 59. LAMEA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 60. LAMEA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 61. PHILIPS: COMPANY SNAPSHOT
TABLE 62. PHILIPS: OPERATING SEGMENTS
TABLE 63. PHILIPS: PRODUCT PORTFOLIO
TABLE 64. MEDTRONIC: COMPANY SNAPSHOT
TABLE 65. MEDTRONIC: OPERATING SEGMENT
TABLE 66. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 67. ABBOTT: COMPANY SNAPSHOT
TABLE 68. ABBOTT: OPERATING SEGMENT
TABLE 69. ABBOTT: PRODUCT PORTFOLIO
TABLE 70. ABBOTT.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 71. BOSTON: COMPANY SNAPSHOT
TABLE 72. BOSTON: OPERATING SEGMENT
TABLE 73. BOSTON: PRODUCT PORTFOLIO
TABLE 74. BOSTON.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 75. BD: COMPANY SNAPSHOT
TABLE 76. BD: OPERATING SEGMENT
TABLE 77. BD: PRODUCT PORTFOLIO
TABLE 78. TERUMO: COMPANY SNAPSHOT
TABLE 79. TERUMO: OPERATING SEGMENT
TABLE 80. TERUMO: PRODUCT PORTFOLIO
TABLE 81. TERUMO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 82. CORDIS: COMPANY SNAPSHOT
TABLE 83. CORDIS: OPERATING SEGMENT
TABLE 84. CORDIS: PRODUCT PORTFOLIO
TABLE 85. B. BRAUN: COMPANY SNAPSHOT
TABLE 86. B. BRAUN: OPERATING SEGMENT
TABLE 87. B. BRAUN: PRODUCT PORTFOLIO
TABLE 88. IVASCULAR: COMPANY SNAPSHOT
TABLE 89. IVASCULAR: OPERATING SEGMENT
TABLE 90. IVASCULAR: PRODUCT PORTFOLIO
TABLE 91. IVASCULAR.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 92. MERIT: COMPANY SNAPSHOT
TABLE 93. MERIT: OPERATING SEGMENT
TABLE 94. MERIT: PRODUCT PORTFOLIO
TABLE 95. MERIT.: KEY STRATEGIC MOVES AND DEVELOPMENTS
List of Figures
FIGURE 01. VASCULAR DISEASE DEVICES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR STENTS BY COUNTRY, 2020 & 2030 (%)
FIGURE 14. VASCULAR DISEASE DEVICES MARKET DRUG-ELUTING STENTS, 2020 & 2030 ($MILLION)
FIGURE 15. VASCULAR DISEASE DEVICES MARKET BARE-METAL CORONARY STENTS, 2020 & 2030 ($MILLION)
FIGURE 16. VASCULAR DISEASE DEVICES MARKET BIOABSORBABLE STENTS, 2020 & 2030 ($MILLION)
FIGURE 17. VASCULAR DISEASE DEVICES MARKET ILIAC ARTERY STENTS, 2020 & 2030 ($MILLION)
FIGURE 18. VASCULAR DISEASE DEVICES MARKET FEMORAL ARTERY STENTS, 2020 & 2030 ($MILLION)
FIGURE 19. VASCULAR DISEASE DEVICES MARKET RENAL ARTERY STENTS, 2020 & 2030 ($MILLION)
FIGURE 20. VASCULAR DISEASE DEVICES MARKET CAROTID ARTERY STENTS, 2020 & 2030 ($MILLION)
FIGURE 21. VASCULAR DISEASE DEVICES MARKET SYNTHETIC GRAFTS, 2020 & 2030 ($MILLION)
FIGURE 22. VASCULAR DISEASE DEVICES MARKET VENA CAVA FILTERS, 2020 & 2030 ($MILLION)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR BALLOONS BY COUNTRY, 2020 & 2030 (%)
FIGURE 24. BARE/NORMAL BALLOON IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 25. DRUG-COATED BALLOON IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 26. SCORING BALLOON IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR CATHETERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 28. ANGIOGRAPHY IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 29. IVUS / OCT IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 30. GUIDING IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 31. COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR PLAQUE MODIFICATION DEVICES BY COUNTRY, 2020 & 2030 (%)
FIGURE 32. COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES BY COUNTRY, 2020 & 2030 (%)
FIGURE 33. COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR OTHERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 34. COMPARATIVE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2020–2030 (%)
FIGURE 35. COMPARATIVE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020–2030 (%)
FIGURE 36. PHILIPS: NET SALES, 2018–2020 ($MILLION)
FIGURE 37. PHILIPS: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 38. PHILIPS: REVENU.S.ARE BY REGION, 2020(%)
FIGURE 39. MEDTRONIC: NET SALES, 2020 ($MILLION)
FIGURE 40. MEDTRONIC: REVENU.S.ARE PER SEGMENT 2020(%)
FIGURE 41. MEDTRONIC: REVENU.S.ARE BY REGION 2020(%)
FIGURE 42. ABBOTT: NET SALES, 2020 ($MILLION)
FIGURE 43. ABBOTT: REVENU.S.ARE PER SEGMENT 2020(%)
FIGURE 44. ABBOTT: REVENU.S.ARE BY REGION 2020(%)
FIGURE 45. BOSTON: NET SALES, 2020 ($MILLION)
FIGURE 46. BOSTON: REVENU.S.ARE PER SEGMENT 2020(%)
FIGURE 47. BOSTON: REVENU.S.ARE BY REGION 2020(%)
FIGURE 48. BD: NET SALES, 2020 ($MILLION)
FIGURE 49. BD: REVENU.S.ARE PER SEGMENT 2020(%)
FIGURE 50. BD: REVENU.S.ARE BY REGION 2020(%)
FIGURE 51. TERUMO: NET SALES, 2020 ($MILLION)
FIGURE 52. TERUMO: REVENU.S.ARE PER SEGMENT 2020(%)
FIGURE 53. TERUMO: REVENU.S.ARE BY REGION 2020(%)
FIGURE 54. CORDIS: NET SALES, 2020 ($MILLION)
FIGURE 55. CORDIS: REVENU.S.ARE PER SEGMENT 2020(%)
FIGURE 56. CORDIS: REVENU.S.ARE BY REGION 2020(%)
FIGURE 57. B. BRAUN: NET SALES, 2020 ($MILLION)
FIGURE 58. B. BRAUN: REVENU.S.ARE PER SEGMENT 2020(%)
FIGURE 59. B. BRAUN: REVENU.S.ARE BY REGION 2020(%)
FIGURE 60. MERIT: NET SALES, 2020 ($MILLION)
FIGURE 61. MERIT: REVENU.S.ARE PER SEGMENT 2020(%)
FIGURE 62. MERIT: REVENU.S.ARE BY REGION 2020(%)

Companies Mentioned

  • Medtronic
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Terumo Corporation, Cordis
  • B. Braun Melsungen Ag
  • Ivascular
  • Merit Medical
  • Koninklijke Philips N.V

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages220
PublishedJanuary 2022
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 26522.24 million
Forecasted Market Value ( USD ) by 2030 $ 51802.14 million
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Hemodynamic flow alteration devices), Region - Forecast to 2029 - Product Image

Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Hemodynamic flow alteration devices), Region - Forecast to 2029

  • Report
  • 324 Pages
  • Global
From
Peripheral Vascular Devices Market Size, Share & Trends Analysis Report by Type, Application (Peripheral Arterial Disease (PAD), Aneurysms, Venous Diseases), End-use (Hospitals, Ambulatory Surgical Centers), Region, and Segment Forecasts, 2025-2030 - Product Image

Peripheral Vascular Devices Market Size, Share & Trends Analysis Report by Type, Application (Peripheral Arterial Disease (PAD), Aneurysms, Venous Diseases), End-use (Hospitals, Ambulatory Surgical Centers), Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Peripheral Vascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Peripheral Vascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Peripheral Vascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Peripheral Vascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 115 Pages
  • Global
From
Peripheral Vascular Devices - Global Strategic Business Report - Product Image

Peripheral Vascular Devices - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.